195 related articles for article (PubMed ID: 34310279)
1. Autoregulatory control of microtubule binding in doublecortin-like kinase 1.
Agulto RL; Rogers MM; Tan TC; Ramkumar A; Downing AM; Bodin H; Castro J; Nowakowski DW; Ori-McKenney KM
Elife; 2021 Jul; 10():. PubMed ID: 34310279
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
Patel O; Dai W; Mentzel M; Griffin MD; Serindoux J; Gay Y; Fischer S; Sterle S; Kropp A; Burns CJ; Ernst M; Buchert M; Lucet IS
Structure; 2016 Sep; 24(9):1550-61. PubMed ID: 27545623
[TBL] [Abstract][Full Text] [Related]
3. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
[TBL] [Abstract][Full Text] [Related]
4. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.
Liu Y; Ferguson FM; Li L; Kuljanin M; Mills CE; Subramanian K; Harshbarger W; Gondi S; Wang J; Sorger PK; Mancias JD; Gray NS; Westover KD
Cell Chem Biol; 2020 Oct; 27(10):1229-1240.e4. PubMed ID: 32755567
[TBL] [Abstract][Full Text] [Related]
5. DCLK1 phosphorylates the microtubule-associated protein MAP7D1 to promote axon elongation in cortical neurons.
Koizumi H; Fujioka H; Togashi K; Thompson J; Yates JR; Gleeson JG; Emoto K
Dev Neurobiol; 2017 Apr; 77(4):493-510. PubMed ID: 27503845
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1.
Patel O; Roy MJ; Kropp A; Hardy JM; Dai W; Lucet IS
Commun Biol; 2021 Sep; 4(1):1105. PubMed ID: 34545159
[TBL] [Abstract][Full Text] [Related]
7. Functional implication of Dclk1 and Dclk1-expressing cells in cancer.
Westphalen CB; Quante M; Wang TC
Small GTPases; 2017 Jul; 8(3):164-171. PubMed ID: 27458755
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.
Ali N; Allam H; Bader T; May R; Basalingappa KM; Berry WL; Chandrakesan P; Qu D; Weygant N; Bronze MS; Umar S; Janknecht R; Sureban SM; Huycke M; Houchen CW
PLoS One; 2013; 8(11):e80304. PubMed ID: 24260365
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells.
Moore LL; Houchen CW
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003596
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation.
Pan P; Ji D; Li Z; Meng X
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2287990. PubMed ID: 38062554
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanism of Mutational Disruption of DCLK1 Autoinhibition Provides a Rationale for Inhibitor Screening.
Chen W; Liu R; Yu Y; Wei D; Chen Q; Xu Q
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762326
[TBL] [Abstract][Full Text] [Related]
12. Doublecortin-like Kinase 1 Regulates α-Synuclein Levels and Toxicity.
Vázquez-Vélez GE; Gonzales KA; Revelli JP; Adamski CJ; Alavi Naini F; Bajić A; Craigen E; Richman R; Heman-Ackah SM; Wood MJA; Rousseaux MWC; Zoghbi HY
J Neurosci; 2020 Jan; 40(2):459-477. PubMed ID: 31748376
[TBL] [Abstract][Full Text] [Related]
13. Doublecortin-Like Kinase 1 Facilitates Dendritic Spine Growth of Pyramidal Neurons in Mouse Prefrontal Cortex.
Murphy KE; Zhang EY; Wyatt EV; Sperringer JE; Duncan BW; Maness PF
Neuroscience; 2023 Jan; 508():98-109. PubMed ID: 36064052
[TBL] [Abstract][Full Text] [Related]
14. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
[TBL] [Abstract][Full Text] [Related]
15. Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ.
Luo W; Jin Y; Jiang Y; Yang L; Xu H; Wu D; Zhang Y; Yin L; Khan ZA; Liang G; Wang Y
Cell Death Differ; 2023 May; 30(5):1184-1197. PubMed ID: 36914767
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury.
Cai B; Xu Y; Luo R; Lu K; Wang Y; Zheng L; Zhang Y; Yin L; Tu L; Luo W; Zheng L; Zhang F; Lv X; Tang Q; Liang G; Chen L
Bioorg Chem; 2024 Apr; 145():107215. PubMed ID: 38394920
[TBL] [Abstract][Full Text] [Related]
17. Research Progress of DCLK1 Inhibitors as Cancer Therapeutics.
Cheng L; Huang S; Chen L; Dong X; Zhang L; Wu C; Ye K; Shao F; Zhu Z; Thorne RF
Curr Med Chem; 2022; 29(13):2261-2273. PubMed ID: 34254905
[TBL] [Abstract][Full Text] [Related]
18. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
Dogra S; Elayapillai SP; Qu D; Pitts K; Filatenkov A; Houchen CW; Berry WL; Moxley K; Hannafon BN
Cancer Lett; 2023 Dec; 578():216437. PubMed ID: 37838282
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
[TBL] [Abstract][Full Text] [Related]
20. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism.
Ali N; Nguyen CB; Chandrakesan P; Wolf RF; Qu D; May R; Goretsky T; Fazili J; Barrett TA; Li M; Huycke MM; Bronze MS; Houchen CW
Sci Rep; 2020 Jun; 10(1):10578. PubMed ID: 32601309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
